Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenwei Yuan

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2016
Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1Chenwei Yuan, Xingwu Zhu, Yang Han, et al.
Frontiers in Oncology|August 28, 2020
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast CancerLei Zhang, Chenwei Yuan, Jing Peng, et al.
Journal of Environmental Management|December 5, 2022
An all-organic conditioning method to achieve deep dewatering of waste activated sludge and the underlying mechanismJie Li, Shaoqin Ru, Chenwei Yuan, et al.
Gland Surgery|July 16, 2021
Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant settingRui Sha, Ziping Wu, Yaqian Xu, et al.
Cancer Letters|September 3, 2023
Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8<sup>+</sup>T anti-tumor immunityWen Qiao, Cegui Hu, Jiayi Ma, et al.
Cell Reports|November 5, 2025
Cancer-associated adipocytes mediate CD8<sup>+</sup>T cell dysfunction via FGF21-driven lipolysisSumiya Dalangood, Cegui Hu, Chenwei Yuan, et al.
Ebiomedicine|September 5, 2021
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapyRui Sha, Yaqian Xu, Chenwei Yuan, et al.
Frontiers in Oncology|May 20, 2020
Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target TherapyShan Zhang, Yaohui Wang, Yan Wang, et al.
Epigenomics|November 13, 2018
Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancerChenwei Yuan, Liheng Zhou, Lei Zhang, et al.
European Journal of Medical Research|September 11, 2024
Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohortChenwei Yuan, Yaqian Xu, Liheng Zhou, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2016
Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1Chenwei Yuan, Xingwu Zhu, Yang Han, et al.
Frontiers in Oncology|August 28, 2020
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast CancerLei Zhang, Chenwei Yuan, Jing Peng, et al.
Journal of Environmental Management|December 5, 2022
An all-organic conditioning method to achieve deep dewatering of waste activated sludge and the underlying mechanismJie Li, Shaoqin Ru, Chenwei Yuan, et al.
Gland Surgery|July 16, 2021
Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant settingRui Sha, Ziping Wu, Yaqian Xu, et al.
Cancer Letters|September 3, 2023
Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8<sup>+</sup>T anti-tumor immunityWen Qiao, Cegui Hu, Jiayi Ma, et al.
Cell Reports|November 5, 2025
Cancer-associated adipocytes mediate CD8<sup>+</sup>T cell dysfunction via FGF21-driven lipolysisSumiya Dalangood, Cegui Hu, Chenwei Yuan, et al.
Ebiomedicine|September 5, 2021
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapyRui Sha, Yaqian Xu, Chenwei Yuan, et al.
Frontiers in Oncology|May 20, 2020
Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target TherapyShan Zhang, Yaohui Wang, Yan Wang, et al.
Epigenomics|November 13, 2018
Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancerChenwei Yuan, Liheng Zhou, Lei Zhang, et al.
European Journal of Medical Research|September 11, 2024
Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohortChenwei Yuan, Yaqian Xu, Liheng Zhou, et al.
Pageof 3